The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Inflammation significantly contributes to the progression of chronic kidney disease (CKD). Inflammasome-dependent cytokines, such as IL-1β and IL-18, play a role in CKD, but their regulation during renal injury is unknown. Here, we analyzed the processing of caspase-1, IL-1β, and IL-18 after unilateral ureteral obstruction (UUO) in mice, which suggested activation of the Nlrp3 inflammasome during renal injury. Compared with wild-type mice, Nlrp3(-/-) mice had less tubular injury, inflammation, and fibrosis after UUO, associated with a reduction in caspase-1 activation and maturation of IL-1β and IL-18; these data confirm that the Nlrp3 inflammasome upregulates these cytokines in the kidney during injury. Bone marrow chimeras revealed that Nlrp3 mediates the injurious/inflammatory processes in both hematopoietic and nonhematopoietic cellular compartments. In tissue from human renal biopsies, a wide variety of nondiabetic kidney diseases exhibited increased expression of NLRP3 mRNA, which correlated with renal function. Taken together, these results strongly support a role for NLRP3 in renal injury and identify the inflammasome as a possible therapeutic target in the treatment of patients with progressive CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Self-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationLiu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Chevalier, R. L., Forbes, M. S., & Thornhill, B. A. (2009) · Kidney International · doi:10.1038/ki.2009.86 · Cited by 1,029
Cited by
Items 401–500 of 603
Protective role of melatonin against diclofenac-induced acute kidney injury
Agaty, S. M. E., Khedr, S., Mostafa, D. K. M., Wanis, N. A., & Abou-Bakr, D. A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122936 · Cited by 13
Bi, X., Wang, J., Liu, Y., Wang, Y., & Ding, W. Q. (2018) · Europe PMC (PubMed Central) · Cited by 13
Kajbaf, F., Oryan, S., Ahmadi, R., & Eidi, A. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100863 · Cited by 13
Interleukin-1 antagonists for diabetes
Mandrup-Poulsen, T. R. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.804060 · Cited by 13
“Islet amyloid polypeptide is deposited in the diabetic glomerulosclerotic process [86] and glomerular IL-1a secretion may contribute to inflammation in diabetic nephropathy [87].”
BackgroundXiang, J., Lv, M., Yuhui, L., Ke, K., Zhang, B., Wang, M., Zhang, K., & Li, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-91460-8 · Cited by 12
“It has shown that molecules of the classical pyroptosis pathway are related to the formation of kidney stones 19,20 .”
Targeted biomarkers of progression in chronic kidney disease
Owens, E. P., Healy, H. G., Vesey, D. A., Hoy, W. E., & Gobe, G. C. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.08.025 · Cited by 13
Research Progress of Pyroptosis in Renal Diseases
Hu, B., Ma, K., Wang, W., Han, Z., Chi, M., Nasser, M. I., & Liu, C. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673255656231003111621 · Cited by 13
Self-citationFeng, J., Li, H., Li, J., Meng, P., Wang, L., Liu, C., Zhao, S., Sun, W., & Zhang, Y. (2020) · Redox Report · doi:10.1080/13510002.2020.1857157 · Cited by 13
“In addition, loss of NLRP3 significantly reduced inflammation and tubulointerstitial fibrosis in mice after unilateral ureteral obstruction [40].”
BackgroundHutton, H., Alikhan, M. A., & Kitching, A. R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_8 · Cited by 16
Hung, T., Hsieh, Y., Lee, H., Ting, Y.-H., Lin, C., & Chao, W. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112314 · Cited by 11
Regulated cell death in chronic kidney disease: current evidence and future clinical perspectives
Giuliani, K. T. K., Adams, B. C., Healy, H. G., & Kassianos, A. J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1497460 · Cited by 11
Deng, Q., Lu, S.-Y., Li, Y., Quan, H., Li, W., Hu, X., Wang, L., & Zhu, Q. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120063 · Cited by 11
Self-citationNutritional Modulation of the Gut–Kidney Axis
Bogdan, R. G., Gligor, F. G., Anderco, P., Popa, M. L., Popescu, A., Bloancă, V., Leonte, E., Iliescu-Glaja, M., Crăiniceanu, Z. P., & Ichim, C. (2026) · Nutrients · doi:10.3390/nu18020263 · Cited by 11
“Data from genetic mouse models indicate that NLRP3-dependent cytokine signaling actively contributes to both CKD progression and ASCVD, rather than merely reflecting secondary activation in advanced disease [192,193].”
Lin, H., Lin, H., Tsai, M.-H., Chen, Y.-J., Bao, B., Tsai, K.-J., Shih, C., Yu, J., Chien, K., Huang, K., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08708-y · Cited by 12
“In addition, the NLRP3 in fl ammasome contributes the development of these diseases [5, 50, 51].”
Nephrotic Syndrome and AA Amyloidosis Revealing Adult-Onset Cryopyrin-Associated Periodic Syndrome
Enríquez, R., Sirvent, A. E., Padilla, S., Noguera-Pons, R., Andrada, E., Ardoy, F., Millán, I., & Amorós, F. (2013) · Renal Failure · doi:10.3109/0886022x.2013.790300 · Cited by 11
“Kidney expression of NLRP3 increases in acute and chronic kidney disease, and IL-1 beta and IL-18 can cause renal fibrosis, suggesting that cryopyrin-inflammasome activation could cause kidney damage.(15) Currently, IL-1 blocking drugs (anakinra, rilonacept, and canakinumab) have replaced corticosteroids and NSAIDs in…”
BackgroundHuoxue Jiedu Huayu Recipe Ameliorates Mesangial Cell Pyroptosis in Contralateral Kidney of UUO Rats
Zhang, Y., Hao, J., Ma, X., Zhao, Q., Gao, X., Wang, X., & Xu, Q. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/2530431 · Cited by 11
“It also has been shown that nucleotide-binding oligomerization domain-like pyrin domain containing protein 3 (NLRP3) inflammasome contributed to the pathogenesis of renal injuries resulting fromUUO [6].”
BackgroundInfluentialLiu, X., Song, W., Zhang, X., Long, F., Yin, J., He, X., & Lv, L. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02369-0 · Cited by 11
Bae, J., Hong, N., Lee, B., Kang, E. S., Soo, B., & Lee, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030798 · Cited by 11
Garcia, J., Steenvoorden, T. S., Bemelman, F. J., Hilhorst, M. L., Tammaro, A., & Vogt, L. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000711 · Cited by 11
Bridging inflammation and venous thrombosis: the NLRP3 inflammasome connection
Wu, J., Wang, Z., Shao, W., & Mo, J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1584745 · Cited by 17
Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives
Vinţeler, N., Feurdean, C. N., Petkes, R., Barabás, R., Boşca, A. B., Muntean, A., Festila, D. G., & Ilea, A. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15020032 · Cited by 10
“The activation of inflammasomes was also observed in patients with diabetes [99], chronic kidney diseases [100] and autoimmune pathologies such as lupus erythematosus [101,102].”
BackgroundLong, C., Zhang, C., & Xie, Y. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02888-6 · Cited by 10
Effect and mechanism of TFEB on pyroptosis in HK-2 cells induced by high glucose
Han, N., Wang, Z., Luo, H., Chi, Y., Zhang, T., Wang, B., & Li, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.062 · Cited by 11
Self-citationGómez-Jaramillo, L., Cano-Cano, F., Sánchez‐Fernández, E. M., Mellet, C. O., Fernández, J. M. G., Alcalá, M., Álvarez-Gallego, F., Iturregui, M., González-Montelongo, M. D. C., Campos‐Caro, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158450 · Cited by 10
“Previous studies have reported reductions in tubular injury, inflammation and fibrosis associated with reduced caspase-1 activation, as well as the failure of IL-1β and IL-18 maturation in kidney-specific NLRP3 knockout mice [46].”
BackgroundHung, C., Chen, K., Hsu, H., Chang, M., Ko, Y.-C., Yang, H., & Yang, C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119594 · Cited by 10
Wang, L., Ding, S., Hu, Y., Su, J., Zhu, G., Hong, H., Hou, B., Dong, Z., Xue, Z., Wang, J., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1513895 · Cited by 13
İlhan, İ., Karakuyu, N. F., Karabacak, P., Milletsever, A., Kolay, Ö., Baysal, G., & Aşçı, H. (2025) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2025.2519597 · Cited by 10
“This process promotes the release of inflammatory mediators in damaged cells, triggering an inflammatory cascade that exacerbates kidney injury [8].”
Sun, Y., Pan, G., Wang, C., & Xiao, Z. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2538798 · Cited by 9
“…elevated expression of the NLrP3 inflammasome in LN patients, with levels of NLrP3 protein positively correlating with serum creatinine, urine protein, and renal pathology [150]. animal studies have demonstrated that silencing or inhibiting NLrP3 can significantly reduce renal damage in LN mice.”
Adipolin protects against renal injury via PPARα-dependent reduction of inflammasome activation
Fang, L., Ohashi, K., Hayakawa, S., Ogawa, H., Otaka, N., Kawanishi, H., Takikawa, T., Ozaki, Y., Takahara, K., Tatsumi, M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106591 · Cited by 9
“NLRP3 deficient mice exhibit reduced tubular injury and fibrosis after unilateral urinary occlusion (UUO).(18) Lack of apoptosis-associated speck-like protein containing CARD, an integral component of the inflammasome, results in attenuated renal injury and fibrosis after UUO.”
BackgroundDeng, Y., Nong, Z., Wei, M., Xu, Y., Luo, Y., Li, X., Zhao, R.-B., Yang, Z., & Pan, L. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2393754 · Cited by 9
“…mucosal barrier [26, 27]. inflammasomes may overactivate mucosal immune inflammatory responses, playing a pivotal role in igan pathogenesis [28–31]. these findings suggest that interventions targeting the gut microbiota-associated bile acid metabolism pathway may provide a novel approach…”
BackgroundProspects for Precision Medicine in Glomerulonephritis Treatment
Liu, Y. C., & Chun, J. (2018) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358117753617 · Cited by 9
“In the Muruve lab, we demonstrated that correlating clinical outcome with RNA expression profiles from kidney biopsies obtained from patient affected with GN is a promising approach to identify biomarkers.(67,68) We anticipate that the biobanked samples will serve as an immense repository for research projects that ca…”
BackgroundSelf-citationHuang, M., Liukang, C., Liang, R., Li, Y., Yang, R., Zhang, M., Zhao, Y., Zhao, J., & Zhang, G. (2025) · Journal of Virology · doi:10.1128/jvi.01466-25 · Cited by 8
“Experimental data show that CEK cells activate the NLRP3 inflammasome upon IBV infection, suggesting that renal epithelial cells are both targets of infection and active contributors to inflammation.”
Self-citationHuang, X. Y., Wang, M. M., Yu, B., Ren, P., Bian, X., Wang, P., Yao, X., & Lin, W. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00462-z · Cited by 10
“It induces the release of proinflammatory cytokines, promotes the upregulation of NLRP3 and caspase-1, and provides the initial signal for NLRP3 inflammasome activation [165, 166].”
Inoue, T., Suzuki, H., & Okada, H. (2012) · Kidney International · doi:10.1038/ki.2012.243 · Cited by 8
Kaspar, C. D. W., & Lü, J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.689219 · Cited by 8
Stroo, I., Emal, D., Butter, L. M., Teske, G. J., Claessen, N., Dessing, M. C., Girardin, S. E., Florquin, S., & Leemans, J. C. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0867-8 · Cited by 9
“lar damage at different phases of UUO [19, 21].”
BackgroundUlke‐Lemée, A., Lau, A. N., Nelson, M. C., James, M. T., Muruve, D. A., & MacDonald, J. A. (2018) · Inflammation · doi:10.1007/s10753-018-0787-6 · Cited by 8
“A growing body of evidence suggests a role for the inflammasome in kidney disease [2, 26, 29, 57], and we successfully applied the MRM-MS assay using SIS heavylabeled peptides for ASC quantification in urine samples obtained from CKD patients.”
BackgroundMethodInfluentialSelf-citationCCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation
Rayego‐Mateos, S., Márquez‐Expósito, L., Basantes, P. E., Tejedor-Santamaria, L., Sanz, A. B., Nguyen, T. Q., Goldschmeding, R., Ortíz, A., & Ruiz‐Ortega, M. (2023) · Antioxidants · doi:10.3390/antiox12081541 · Cited by 13
The Impact of Regulated Cell Death Pathways on Alloimmune Responses and Graft Injury
Hébert, M., & Jevnikar, A. M. (2015) · Current Transplantation Reports · doi:10.1007/s40472-015-0067-4 · Cited by 8
Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury
Guo, H., Li, H., Ling, L., Gu, Y., & Ding, W. Q. (2016) · Mediators of Inflammation · doi:10.1155/2016/4387031 · Cited by 8
Calle, P., Torrico, S., Muñoz, A., & Hotter, G. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.121 · Cited by 9
“NLRP3 is involved in chronic kidney disease (CKD) pathogenesis [19].”
BackgroundEstablishment of a Stable Acute Drug-Induced Liver Injury Mouse Model by Sodium Cyclamate
Zhou, Q., Peng, Z., & Huang, X. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s354273 · Cited by 8
“The release of IL-1β makes neutrophils gather in the renal interstitium.(32) After the renal interstitium damaged, causes the dysuria and impaired urine reabsorption.”
BackgroundUromodulin, Inflammasomes, and Pyroptosis
Sánchez-Niño, M. D., Sanz, A. B., & Ortíz, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090942 · Cited by 8
“This information is consistent with prior data, in which low pro-IL-1b and pro-IL-18 levels of expression in cultured tubular cells prevents the study of the role of NLRP3 in cytokine processing.(11) In addition, tubular cells might lack efficient uromodulin phagocytosis.”
BackgroundResultTrials and Tribulations of New Agents, Novel Biomarkers, and Retarding Renal Progression
Levin, A., & Beaulieu, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040402 · Cited by 8
Interplay Between the Mineralocorticoid System, Inflammation, Hypertension, and Kidney Disease
Fields, E., & Schiffrin, E. L. (2025) · Kidney360 · doi:10.34067/kid.0000000929 · Cited by 7
Wang, Y., Shi, Y., Zhang, X., Fu, J., & Chen, F. (2021) · BioMed Research International · doi:10.1155/2021/4084371 · Cited by 8
“NLRP3 inflammasome has been linked with various human inflammatory diseases including chronic kidney disease [14], gout [15], and ALI [16].”
BackgroundHsueh, Y., Chen, W., Lin, Y., Huang, Y., Shiue, H.-S., Lin, Y., Hsieh, R., & Chen, H.-H. (2022) · Scientific Reports · doi:10.1038/s41598-022-10098-y · Cited by 7
Zhang, Y., Huang, L., & Ou, S. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2435485 · Cited by 7
“In addition, activation of the NLRP3 inflammasome has been demonstrated to promote VC both in vivo and in vitro [39].”
Rahman, M. A., Datta, S., Lakkakula, H., Koka, S., & Boini, K. M. (2025) · Biomedicines · doi:10.3390/biomedicines13020416 · Cited by 7
“…diabetes, silicosis, obesity, gout, chronic kidney disease, acetaminophen-induced liver toxicity [19–26], unilateral ureteral obstruction [27,28], nicotine-induced atherosclerosis [29], kidney injury caused by acute ischemia followed by reperfusion [30], non-diabetic kidney disease [28],…”
The Nucleotide Oligomerization Domain-Like Receptors in Kidney Injury
Wang, X., & Yi, F. (2016) · Kidney Diseases · doi:10.1159/000444736 · Cited by 8
Inflammation in Chronic Kidney Disease
Raj, D. S., Pecoits‐Filho, R., & Kimmel, P. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00024-3 · Cited by 13
A contemporary review of nephrotoxicity and e-cigarette use
Raja, A., Zelikoff, J. T., & Jaimes, E. A. (2022) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2022.100361 · Cited by 7
Niu, S., Lin, H. Y., Kuo, I., Zhen, Y., Chang, E.-E., Shen, F., Chiu, Y., Chang, J., Hung, C., & Hwang, S. (2022) · Biomedicines · doi:10.3390/biomedicines10071719 · Cited by 7
“Proinflammatory cytokines (IL-1β and IL-18) [34] and active inflammasomes result in the development and progression of tubulointerstitial disease [35].”
BackgroundRole and new insights of microfibrillar‐associated protein 4 in fibrotic diseases
Zhu, L., Gou, W., Ou, L., Liu, B., Liu, M., & Feng, H. (2023) · Apmis · doi:10.1111/apm.13358 · Cited by 7
“Statistically, in Western developed countries, approximately 45% of cases of fibrotic diseases resulted in death [1, 2].”
BackgroundMetaflammation, NLRP3 Inflammasome Obesity and Metabolic Disease
Meiliana, A., & Wijaya, A. (2011) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v3i3.148 · Cited by 8
Chiu, H., Huang, W., Ho, C., Wang, J., Lin, S., Hsu, Y., & Chen, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180446 · Cited by 7
Kidney surveillance in the spotlight: contrast-induced acute kidney injury illuminated
Atkinson, S. J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121741 · Cited by 7
Chronic kidney disease-associated cardiomyopathy: clinical features, pathophysiology and treatment
Edwards, N. C., Pavlovic, D., Ferro, C. J., & Townend, J. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01234-y · Cited by 8
“The NLRP3 inflammasome has also been implicated as one of the drivers of CKD, including renal fibrosis, as evidenced by data from both animal models and patients 101,102 .”
Serum interleukin 18 level in kidney diseases and age
Radwan, G. A. E., Yousef, A. E.-S., & Bayomy, M. F. F. (2024) · Urology Annals · doi:10.4103/ua.ua_140_22 · Cited by 6
“[14] IL‑1 β and IL‑18 are two examples of the many pro‑inflammatory cytokines that are produced under the direction of the inflammasome, which is activated and then assembled.”
BackgroundLoss of NLRP6 increases the severity of kidney fibrosis
Rivas, L. V., Chocano, A. P., Carriazo, S. M., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31347 · Cited by 7
“…eGFR in 3 datasets, validating the experimental approach as this finding was concordant with the literature on NLRP3 and CKD progression (Anders et al., 2018; Bakker et al., 2014b; Gong et al., 2016; Krishnan et al., 2019; Ludwig ‐ Portugall et al., 2016; Vilaysane et al., 2010; Wu et al., 2018a).”
Hirudin alleviates renal fibrosis by inducing autophagy to suppress NLRP3 inflammasome activation
Long, C., Lan, F., Xie, H., Chen, J., & Xie, Y. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf114 · Cited by 6
Adachi, E., Murakoshi, M., Shibata, T., Shimozawa, K., Sakuma, H., Kishida, C., Gohda, T., & Suzuki, Y. (2024) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.23-0080 · Cited by 7
“The percentage of cortical tubular necrosis was assigned using the following grades: grade 0, normal; 1, <20%; 2, 20–40%; 3, 40–60%; 4, 60–80%; and 5, >80%, as described previously [ 14].”
Lin, C., & Shih, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126686 · Cited by 6
“Inflammasome formation is important for the autoprocessing of caspase-1 and the activation of the cytokines pro-IL-1b and pro-IL-18 [39].”
BackgroundXu, Y., Liu, Y., Guo, H., & Ding, W. Q. (2018) · Mediators of Inflammation · doi:10.1155/2018/6909035 · Cited by 6
The Role of Inflammasomes in Mediating Urological Disease: A Short Literature Review
Shidid, S., Bluth, M. H., & Smith-Norowitz, T. A. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s370451 · Cited by 6
“The NLRP3 inflammasome’s repertoire of roles is important to comprehend because of its ability to exacerbate renal inflammation, end-stage renal disease, and chronic kidney disease.(17) There are minimal options to treat chronic kidney disease, making the quest to understand the pathophysiology of the disease more imp…”
BackgroundInflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration
Gašparini, D., Wensveen, F. M., & Wensveen, T. T. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111056 · Cited by 6
Kidney Disease and Gout: The Role of the Innate Immune System
Finn, W. F. (2016) · The Open Urology & Nephrology Journal · doi:10.2174/1874303x01609010012 · Cited by 6
“To mention a few, in subjects with chronic kidney disease levels of mRNA encoding NLRP3 correlate with renal function [52].”
Inflammation in Nonimmune-Mediated Chronic Kidney Disease
Fanelli, C., Noreddin, A. M., & Nunes, A. C. F. (2018) · InTech eBooks · doi:10.5772/intechopen.70611 · Cited by 10
“2010 [41] Mouse Unilateral ureteral obstruction (UUO) NLRP3”
Huang, Y., Li, C., Xu, W., Li, F., Xu, C., Wu, C., Wang, Y., Zhang, X., & Xia, D. (2023) · Research Square · doi:10.21203/rs.3.rs-2946547/v1 · Cited by 6
The pyroptosis and fibrotic diseases: a bibliometric analysis from 2010 to 2024
Zhu, L., Ou, L., Liu, B., Yang, Y., Su, C., Liu, O., & Feng, H. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02703-0 · Cited by 5
“In unilateral ureteral occlusion, both NLRP3 and caspase-1 expression were significantly elevated, while renal fibrosis was reduced in the NLRP3 − / − condition [18, 50].”
From Gene to Clinic: The Role of APOL1 in Focal Segmental Glomerulosclerosis
Delrue, C., & Speeckaert, M. M. (2025) · Sclerosis · doi:10.3390/sclerosis3010006 · Cited by 5
Yan, L., Zeng, Q., Wang, W., Liang, Y. J., Lang, R., Zhan, J., Yang, J., Yu, R., & Wang, X. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120291 · Cited by 7
Self-citationTargeting Aquaporins for Renal Fibrosis Therapy: Mechanisms and Translational Potential
Sang, Y., Dai, R., Cheng, M., Chen, Y., Wang, W., Wei, L., Li, H., Li, Y., Wang, Y., & Zhang, L. (2025) · The FASEB Journal · doi:10.1096/fj.202501710r · Cited by 5
Self-citationResveratrol as a naturally occurring inflammasome modulator: Implications for health and disease.
Rahbardar, M. G., & Sahebkar, A. (2025) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2025.87366.18879 · Cited by 8
“In renal disorders such as chronic kidney disease, inflammasome activation and subsequent cytokine release contribute to chronic inflammation and tissue damage (121, 122).”
Targeting Hsp90α to inhibit HMGB1‐mediated renal inflammation and fibrosis
Wei, H., Ren, J., Feng, X., Zhao, C., Zhang, Y., Yuan, H., Yang, F., & Li, Q. (2024) · Cell Proliferation · doi:10.1111/cpr.13774 · Cited by 5
Li, S., Zhang, Y., & Wei, W. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103381 · Cited by 5
The role and mechanism of RIPK1 in vascular endothelial dysfunction in chronic kidney disease
Wang, C., Chen, H., Su, H. Y., Sheng, Q., Lang, Y., Yu, Q., Lv, Z., & Wang, R. (2024) · The FASEB Journal · doi:10.1096/fj.202301916rr · Cited by 5
“23 In addition, deletion of NLRP3 improved mitochondrial function and reduced proteinuria and CKD-associated inflammation in five of six nephrectomy model.”
BackgroundRole of inflammasomes in pathogenesis of diseases with a high impact on public health
Пирожков, С. В., & Литвицкий, П. Ф. (2018) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2018.01.77-89 · Cited by 6
Pereira, M. M., Torrado, J., Sosa, C., Zócalo, Y., & Bia, D. (2021) · Current Hypertension Reviews · doi:10.2174/1573402117666210218105951 · Cited by 5
Tang, S., Sumitra, M. R., Chen, L.-C., Liu, F., Hsu, H.-L., Kuo, Y., Ansar, M., Huang, S., Lee, S., Wang, H.-J., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111110 · Cited by 5
AlRamadneh, T. N., Abdulsahib, W. K., Ismail, S. H., Roopashree, R., Mohanty, B., Nandhini, S. U., Arora, V., Chauhan, A. S., & Farhood, B. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2598564 · Cited by 5
“Investigations have shown that deletion of NLRP3, an essential component of innate immunity, has preventive effects against renal fibrosis progression (Vilaysane et al. 2010; Artlett and Thacker 2015), and the NLRP3 inflammasome suppression delays CKD (Bugyei-Twum et al. 2016).”
Ischemia–Reperfusion Injury: Molecular Mechanisms and Therapeutic Interventions
An, P., An, Y., Chen, M., Wu, L., & Wang, R. (2026) · MedComm · doi:10.1002/mco2.70822 · Cited by 5
Metabolic characteristics and renal dysfunction in 65 patients with tophi prior to gout
Lu, C.-C., Wu, S., Chung, W., Lin, L.-H., Hung, T.-W., & Yeh, C. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3663-0 · Cited by 4
Hirano, A., Kadoya, H., Yamanouchi, Y., Kishi, S., Sasaki, T., & Kashihara, N. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03431-8 · Cited by 4
“The NLRP3 inflammasome can trigger chronic low-grade inflammation [8] and the pathogenesis of multiple complex diseases, including chronic kidney disease [9], atherosclerosis [10], type 2 diabetes [11], and Alzheimer’s disease [12].”
BackgroundGe, P., Guo, Y., Che, B., Jin, H., Chen, L., Chen, Z., & Tang, K. (2025) · American Journal of Men s Health · doi:10.1177/15579883251318307 · Cited by 4
Effects of cell-type-specific expression of a pan-caspase inhibitor on renal fibrogenesis
Inoue, T., Kusano, T., Tomori, K., Nakamoto, H., Suzuki, H., & Okada, H. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1011-0 · Cited by 4
“The involvement of TLRs in renal injury following UUO has been tested with inconsistent results [26, 27], while the NLRP3 inflammasome was revealed to be involved in obstructive nephropathy following UUO [25].”
BackgroundEmlet, D. R., Gómez, H., & Kellum, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00021-2 · Cited by 5
Na, S. W., Jang, Y. J., Hong, M. H., Yoon, J. J., Lee, H. S., Kim, H. Y., & Kang, D. G. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/7178868 · Cited by 8
“In inflammatory kidney diseases, the nucleotide-binding oligomerization domainlike receptor pyrin domain containing-3 (NLRP3) inflammasome is a multi-protein complex induced by harmful factors in the body and plays an essential role in the inflammatory response [7, 8].”
BackgroundIbrutinib does not prevent kidney fibrosis following acute and chronic injury
Bellière, J., Casemayou, A., Colliou, É., Hachem, H. E., Kounde, C., Piedrafita, A., Feuillet, G., Schanstra, J. P., & Faguer, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-91491-x · Cited by 5
NLRP3 Inflammasome in Cardiovascular Disease: David's Stone against Goliath?
Balanescu, S. M., Barbu, E. M., Georgescu, C., & Popescu, A. C. (2021) · Romanian Journal of Cardiology · doi:10.47803/rjc.2021.31.3.517 · Cited by 4
Huang, S., Yu, T., Chen, C., Cheng, Y.-C., Chuang, Y., Cheng, C.-H., Liu, J., Hsu, C., & Wu, M. (2023) · Metabolites · doi:10.3390/metabo13020266 · Cited by 5
Saikia, R., Choudhury, S. R., Borah, A., & Mazumder, M. K. (2019) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-019-00402-z · Cited by 4
Minding the Gap: Connexin40 at the Heart of Renin Release
Facemire, C. S., & Gurley, S. B. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040395 · Cited by 4
The renal immune-inflammatory component of arterial hypertension: emerging therapeutic strategies
García-Fernández, N., Beaumont, J., Moreno, M. U., José, G. S., González, A., & Díez, J. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy280 · Cited by 4
Ma, Y., Peng, L., Song, H., Gu, J., Sheng, Q., Geng, B., Wei, H., Chang, W., Xiao, M., Gao, F., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157653 · Cited by 3
Research progress on the role of mesenchymal stem cells in pyroptosis in sepsis
Xu, X., An, J., Yang, T., Li, B., & Dou, Z. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04837-x · Cited by 4
“In sepsis-associated acute kidney injury (AKI), renal inflammatory responses are markedly amplified, accompanied by a significant up-regulation of NLRP3 within kidney tissue [118].”
Navghare, A. A., Rajput, S., Yadav, P., Singh, S. K., Goswami, Y., Bhatti, J. S., & Navik, U. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04869-3 · Cited by 3
Stimulator of Interferon Genes Is a Fine-Tuner, but Not a Prime Mover, of Kidney Inflammation
Syeda, M. Z., Yeung, E. S. H., Hong, L. Y. Q., Advani, S. L., Liu, Y., Geldenhuys, L., Siddiqi, F. S., Yerra, V. G., Batchu, S. N., & Advani, A. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.10.013 · Cited by 3
“23 Yet, in the Canakinumab Antiinflammatory Thrombosis Outcome Study, while reducing cardiovascular events, 24 treatment with a monoclonal antibody directed against IL-1 β (an effector of the NLRP3 inflammasome) resulted in a worsening of estimated glomerular filtration rate in participants with…”
Research advances on NLRP3 inflammasomes in organ transplantation
Wang, K., Luo, H., Ma, X., Zhang, Y., Chen, Y.-X., Li, T., Wang, Y., & Jiang, H.-T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1726601 · Cited by 3
Atmospheric stressors and kidney diseases
Ahn, S., Yun, H., Kim, S., Al‐Aly, Z., Bell, M. L., & Lee, W. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01073-1 · Cited by 4
“In particular, PM 2.5 activates the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome, leading to increased systemic levels of IL-1β, IL-18, MIP-1α and MCP-1, which contribute to renal inflammation and fibrosis 53 .”
Influential
Metadata
- Authors
- Vilaysane, A., Chun, J., Seamone, M. E., Wang, W., Chin, R., Hirota, S., Li, Y., Clark, S. A., Tschopp, J., Trpkov, K., Hemmelgarn, B. R., Beck, P. L., & Muruve, D. A.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Vilaysane, Akosua
- Chun, Justin
- Seamone, Mark E.
- Wang, Wenjie
- Chin, Rick
- Hirota, Simon
- Li, Yan
- Clark, Sharon A.
- Hemmelgarn, Brenda R.
- Beck, Paul L.
- Muruve, Daniel A.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2010-10
- Volume
- 21
- Issue
- 10
- Pages
- 1732-1744
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3013544
- OpenAlex
- W2111994713
- Cited by
- 587
- References
- 44
- Citations by year
- 2026: 30 · 2025: 44 · 2024: 48 · 2023: 40 · 2022: 50 · 2021: 42 · 2020: 43 · 2019: 42 · 2018: 46 · 2017: 36 · 2016: 44 · 2015: 29 · 2014: 36 · 2013: 26 · 2012: 16
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- NLRP3 inflammasome, chronic kidney disease, renal inflammation, caspase-1, IL-1β, IL-18, unilateral ureteral obstruction, renal tubular injury, renal fibrosis, non-diabetic kidney disease, therapeutic target
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cells, Cultured, Fibrosis, Humans, Kidney, Male, Mice, Inbred C57BL, Nephritis, RNA, Messenger, Ureteral Obstruction, Mice, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.